The novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) was declared a pandemic by the WHO on 19 March …

The renin-angiotensin system (RAS) is an important therapeutic target in the treatment of
hypertension. Obesity has emerged as a primary contributor to essential hypertension in the …

The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to …

The renin‐angiotensin system (RAS) is a critical regulator of hypertension, primarily through
the actions of the vasoactive peptide Ang II, which is generated by the action of angiotensin …

Disturbances in fatty acid metabolism in adipose tissue, liver, skeletal muscle, gut and
pancreas play an important role in the development of insulin resistance, impaired glucose …

Postprandial hyperglycemia plays an important role in the development of type 2 diabetes
and has been proposed as an independent risk factor for cardiovascular diseases. The …

Abstract Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-
angiotensin system, provides protection against several chronic diseases. Besides chronic …

Recent trials have suggested that inhibitors of the renin–angiotensin system (RAS), such as
angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers …

Diabetes mellitus is a growing problem in all parts of the world. Both clinical trials and
animal models of type I and type II diabetes have shown that hyperactivity of angiotensin-II …

The incidence of metabolic syndrome is rapidly increasing in the United States and
worldwide. The metabolic syndrome is a complex metabolic and vascular disorder that is …